Unique approaches are needed to bring solutions to fighting cancer and bacterial-resistant infections.
Sandra Von Meier
Advertisement
Sandra Von Meier is head of business development at Debiopharm.
Articles by Sandra Von Meier
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
